Diminished gallbladder motility in Rotund leptin-resistant obese mice.

BACKGROUND Obesity is a risk factor for cholesterol gallstone formation, but the pathogenesis of this phenomenon remains unclear. Most human obesity is associated with diabetes and leptin-resistance. Previous studies from this laboratory have demonstrated that diabetic leptin-resistant (Lep(db)) obese mice have low biliary cholesterol saturation indices, enlarged gallbladders and diminished gallbladder response to neurotransmitters. Recently, a novel leptin-resistant mouse strain Lepr(db-rtnd) (Rotund) has been discovered. Rotund mice are also obese, diabetic, and have an abnormal leptin receptor. Therefore, we tested the hypothesis that leptin-resistant obese Rotund mice would have large gallbladders and reduced biliary motility. METHODS Eight-week-old control (C57BL/6J, N=12) and Rotund leptin-resistant (Lepr(db-rnd), N=9) mice were fed a non- lithogenic diet for four weeks. Animals were fasted and underwent cholecystectomy. Gallbladder volumes were recorded, and contractile responses (N/cm(2)) to acetylcholine (10(-5) M), Neuropeptide Y (10(-8,-7,-6) M), and cholecystokinin (10(-10,-9,-8,-7) M) were measured. Results were analyzed using the Mann-Whitney Rank Sum Test. RESULTS Compared to control mice, Rotund mice had larger body weights, higher serum glucose levels, and greater gallbladder volumes (p<0.05). Rotund gallbladders had less contractility (p<0.05)) to acetylcholine and cholecystokinin than control mice. Responses to Neuropeptide Y were also less, but not statistically significant, in the Rotund mice. CONCLUSIONS These data suggest that leptin-resistant Rotund mice have (1) enlarged gallbladders with (2) diminished contractility compared to lean control mice. Therefore, this study confirms that leptin-resistance is associated with abnormal biliary motility and may lead to gallstone formation in leptin-resistant obesity.

[1]  H. Pitt,et al.  Nonobese diabetic mice have diminished gallbladder motility and shortened crystal observation time , 2004, Journal of Gastrointestinal Surgery.

[2]  H. Pitt,et al.  Gallbladder myocytes are short and cholecystokinin-resistant in obese diabetic mice. , 2004, Surgery.

[3]  P. Muzzin,et al.  Changes in glycemia by leptin administration or high- fat feeding in rodent models of obesity/type 2 diabetes suggest a link between resistin expression and control of glucose homeostasis. , 2004, Endocrinology.

[4]  K. Mak,et al.  Leptin Stimulates Tissue Inhibitor of Metalloproteinase-1 in Human Hepatic Stellate Cells , 2004, Journal of Biological Chemistry.

[5]  H. Pitt,et al.  Leptin-resistant obese mice do not form biliary crystals on a high cholesterol diet. , 2003, The Journal of surgical research.

[6]  H. Pitt,et al.  Leptin-resistant obese mice have paradoxically low biliary cholesterol saturation. , 2003, Surgery.

[7]  H. Pitt,et al.  Gallbladder motility in agouti-yellow and leptin-resistant obese mice. , 2003, The Journal of surgical research.

[8]  J. Naggert,et al.  New leptin receptor mutations in mice: Lepr(db-rtnd), Lepr(db-dmpg) and Lepr(db-rlpy). , 2003, The Journal of nutrition.

[9]  G. Kisakol,et al.  Real-time sonography for screening of gallbladder motility in diabetic patients: relation to autonomic and peripheral neuropathy. , 2003, Neuro endocrinology letters.

[10]  H. Pitt,et al.  Diabetes and hyperlipidemia correlate with gallbladder contractility in leptin-related murine obesity , 2003, Journal of Gastrointestinal Surgery.

[11]  A. Mokdad,et al.  Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. , 2003, JAMA.

[12]  B. Paigen,et al.  Cholesterol gallstone formation in overweight mice establishes that obesity per se is not linked directly to cholelithiasis risk DOI 10.1194/jlr.M200102-JLR200 , 2002, Journal of Lipid Research.

[13]  Lisa J. Martin,et al.  Gallstones: Genetics Versus Environment , 2002, Annals of surgery.

[14]  H. Pitt,et al.  Decreased gallbladder response in leptin-deficient obese mice , 2001, Journal of Gastrointestinal Surgery.

[15]  A. Barden,et al.  Advanced Glycation End Products: A Review , 2013 .

[16]  H. Parkman,et al.  Subtypes of muscarinic receptors regulating gallbladder cholinergic contractions. , 1998, American journal of physiology. Gastrointestinal and liver physiology.

[17]  K. Harnett,et al.  Signal transduction pathways mediating CCK-induced gallbladder muscle contraction. , 1998, American journal of physiology. Gastrointestinal and liver physiology.

[18]  G. Mawe,et al.  Innervation of the gallbladder: Structure, neurochemical coding, and physiological properties of guinea pig gallbladder ganglia , 1997, Microscopy research and technique.

[19]  J. Hahm,et al.  Gallbladder motility in diabetes mellitus using real time ultrasonography. , 1996, The American journal of gastroenterology.

[20]  J. Darnell,et al.  Leptin activation of Stat3 in the hypothalamus of wild–type and ob/ob mice but not db/db mice , 1996, Nature Genetics.

[21]  Rene Devos,et al.  Identification and expression cloning of a leptin receptor, OB-R , 1995, Cell.

[22]  J. Grider Role of cholecystokinin in the regulation of gastrointestinal motility. , 1994, The Journal of nutrition.

[23]  W. dodds,et al.  Mechanism of cholecystokinin-induced contraction of the opossum gallbladder. , 1990, Gastroenterology.